Inhibiting NK1R exerted a neuroprotective effect in various neurological disease models, such as traumatic brain injury, cerebral infarction, encephalitis, and subarachnoid hemorrhage [36, 50–52]. This evidence concerns the gene TACR1 and cerebral infarction.